185 related articles for article (PubMed ID: 9652345)
1. Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissues.
O'Malley SS; Chen TB; Francis BE; Gibson RE; Burns HD; DiSalvo J; Bayne ML; Wetzel JM; Nagarathnam D; Marzabadi M; Gluchowski C; Chang RS
Eur J Pharmacol; 1998 May; 348(2-3):287-95. PubMed ID: 9652345
[TBL] [Abstract][Full Text] [Related]
2. In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonist.
Chang RS; Chen TB; O'Malley SS; Pettibone DJ; DiSalvo J; Francis B; Bock MG; Freidinger R; Nagarathnam D; Miao SW; Shen Q; Lagu B; Murali Dhar TG; Tyagarajan S; Marzabadi MR; Wong WC; Gluchowski C; Forray C
Eur J Pharmacol; 2000 Dec; 409(3):301-12. PubMed ID: 11108825
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.
Kenny BA; Naylor AM; Greengrass PM; Russell MJ; Friend SJ; Read AM; Wyllie MG
Br J Pharmacol; 1994 Apr; 111(4):1003-8. PubMed ID: 7913370
[TBL] [Abstract][Full Text] [Related]
4. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
[TBL] [Abstract][Full Text] [Related]
6. Buspirone functionally discriminates tissues endowed with alpha1-adrenoceptor subtypes A, B, D and L.
Eltze M; König H; Ullrich B; Grebe T
Eur J Pharmacol; 1999 Jul; 378(1):69-83. PubMed ID: 10478567
[TBL] [Abstract][Full Text] [Related]
7. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
[TBL] [Abstract][Full Text] [Related]
8. Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart.
Michel MC; Hanft G; Gross G
Br J Pharmacol; 1994 Feb; 111(2):533-8. PubMed ID: 7911718
[TBL] [Abstract][Full Text] [Related]
9. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
Yamada S; Ohkura T; Deguchi Y; Kimura R
J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
[TBL] [Abstract][Full Text] [Related]
10. Is alpha1D-adrenoceptor protein detectable in rat tissues?
Yang M; Verfürth F; Büscher R; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):438-46. PubMed ID: 9109358
[TBL] [Abstract][Full Text] [Related]
11. Characterization of alpha1-adrenoceptor subtypes in the pig.
Wikberg-Matsson A; Wikberg JE; Uhlén S
Eur J Pharmacol; 1998 Apr; 347(2-3):301-9. PubMed ID: 9653897
[TBL] [Abstract][Full Text] [Related]
12. Properties of alpha-1-adrenergic receptors in the rat prostate: effect of experimental diabetes.
Nishi K; Wada Y; Saito M; Foster HE; Weiss RM; Latifpour J
Urol Int; 1998; 61(3):147-53. PubMed ID: 9933834
[TBL] [Abstract][Full Text] [Related]
13. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
Yamada S; Okura T; Kimura R
J Pharmacol Exp Ther; 2001 Jan; 296(1):160-7. PubMed ID: 11123376
[TBL] [Abstract][Full Text] [Related]
14. Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies.
Yang M; Reese J; Cotecchia S; Michel MC
J Pharmacol Exp Ther; 1998 Aug; 286(2):841-7. PubMed ID: 9694940
[TBL] [Abstract][Full Text] [Related]
15. [3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin.
Ireland LM; Cain JC; Rotert G; Thomas S; Shoghi S; Hancock AA; Kerwin JF
Eur J Pharmacol; 1997 May; 327(1):79-86. PubMed ID: 9185839
[TBL] [Abstract][Full Text] [Related]
16. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
[TBL] [Abstract][Full Text] [Related]
18. Determination of alpha 1-adrenoceptor subtype selectivity by [3H]-prazosin displacement studies in guinea-pig cerebral cortex and rat spleen membranes.
Veenstra DM; van Buuren KJ; Nijkamp FP
Br J Pharmacol; 1992 Sep; 107(1):202-6. PubMed ID: 1358383
[TBL] [Abstract][Full Text] [Related]
19. Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen.
Teng CM; Guh JH; Ko FN
Eur J Pharmacol; 1994 Nov; 265(1-2):61-6. PubMed ID: 7883030
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
Murata S; Taniguchi T; Muramatsu I
Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
